Embecta makes pen needles, insulin syringes and safety injection devices for people with diabetes. It last closed at $6.15 on Nov 17, down 1.60% on the day. EMBC reports earnings on Tue, Nov 24, 2026.
EMBC · as of the Nov 17 close · updated after every close
Moving sideways
The stock sits between its 20 and 50 day averages. It is sitting right on its 200 day average, a level many traders watch. Momentum is fading (RSI 47). The nearest support is the 200 day average at $6.14, and the nearest resistance the swing high (Oct 7) at $6.16.
Short trendNeutral
Long trendBearish
MomentumFading
StretchNormal
VolatilityNormal, 5.1%/day
Key levels
$14.8152 week high+140.8%
$6.4420 day average+4.7%
$6.27Pivot R1+2.0%
$6.16Swing high (Oct 7)+0.2%
$6.15Last close
$6.14200 day average−0.2%
$6.14Pivot−0.2%
$6.03Pivot S1−2.0%
$5.9950 day average−2.6%
$5.78Swing low (Nov 6)−6.0%
$5.08100 day average−17.4%
$2.7752 week low−55.0%
Indicators
RSI (14)
47.05
Middle of its range
Neutral
MACD
0.07
Below its signal line
Bearish
Stochastic
48.2
Middle of its range
Neutral
ADX (14)
18.6
No clear trend
Williams %R
-63.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-118.5
Oversold below −100, overbought above 100
Oversold
Rate of change
+1.1%
Change over 10 sessions
Bullish
ATR (14)
$0.31
Typical daily range, 5.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumImproving
StretchNormal
VolatilityNormal, 12.0%/day
Key levels
$14.8152 week high+140.8%
$6.4420 day average+4.7%
$6.27Pivot R1+2.0%
$6.16Swing high (Oct 7)+0.2%
$6.15Last close
$6.14200 day average−0.2%
$6.14Pivot−0.2%
$6.03Pivot S1−2.0%
$5.9950 day average−2.6%
$5.78Swing low (Nov 6)−6.0%
$5.08100 day average−17.4%
$2.7752 week low−55.0%
Indicators
RSI (14)
52.01
Middle of its range
Neutral
MACD
-0.01
Above its signal line
Bullish
Stochastic
75.8
Middle of its range
Neutral
ADX (14)
22.8
Weak trend
Williams %R
-35.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
77.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+24.5%
Change over 10 sessions
Bullish
ATR (14)
$0.74
Typical daily range, 12.0% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200–
What happened before, for EMBC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how EMBC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Earnings in 6 daysSignals right before a report are less reliable. The report can override them.
November seasonalityHow EMBC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How EMBC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2022.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EMBC is in one of them and how their past EMBC trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Embecta
Embecta is a medical device company focused on helping people with diabetes manage insulin injections. Its main products are pen needles, insulin syringes and safety injection devices, which are designed to work with insulin pens and vials and to help protect users and healthcare workers from needlestick injuries. The company sells to patients, retailers, hospitals, pharmacies and other healthcare providers in many countries. It is based in Parsippany, New Jersey.